In vivo roles of factor XII T Renné, AH Schmaier, KF Nickel, M Blombäck, C Maas Blood 120 (22), 4296, 2012 | 420 | 2012 |
Mast cells increase vascular permeability by heparin-initiated bradykinin formation in vivo C Oschatz, C Maas, B Lecher, T Jansen, J Björkqvist, T Tradler, ... Immunity 34 (2), 258-268, 2011 | 303 | 2011 |
Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation C Maas, JWP Govers-Riemslag, B Bouma, B Schiks, BPC Hazenberg, ... The Journal of clinical investigation 118 (9), 3208, 2008 | 290 | 2008 |
Antibody response to aggregated human interferon alpha2b in wild‐type and transgenic immune tolerant mice depends on type and level of aggregation S Hermeling, H Schellekens, C Maas, MFBG Gebbink, DJA Crommelin, ... Journal of pharmaceutical sciences 95 (5), 1084-1096, 2006 | 258 | 2006 |
Coagulation factor XII in thrombosis and inflammation C Maas, T Renné Blood, The Journal of the American Society of Hematology 131 (17), 1903-1909, 2018 | 225 | 2018 |
Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III J Björkqvist, S de Maat, U Lewandrowski, A Di Gennaro, C Oschatz, ... The Journal of clinical investigation 125 (8), 3132-3146, 2015 | 185 | 2015 |
A role for protein misfolding in immunogenicity of biopharmaceuticals C Maas, S Hermeling, B Bouma, W Jiskoot, MFBG Gebbink Journal of Biological Chemistry 282 (4), 2229, 2007 | 183 | 2007 |
Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations S de Maat, J Björkqvist, C Suffritti, CP Wiesenekker, W Nagtegaal, ... Journal of Allergy and Clinical Immunology 138 (5), 1414-1423. e9, 2016 | 180 | 2016 |
Plasma contact system activation drives anaphylaxis in severe mast cell–mediated allergic reactions A Sala-Cunill, J Björkqvist, R Senter, M Guilarte, V Cardona, M Labrador, ... Journal of Allergy and Clinical Immunology 135 (4), 1031-1043. e6, 2015 | 164 | 2015 |
The plasma contact system 2.0 C Maas, C Oschatz, T Renné Seminars in thrombosis and hemostasis 37 (04), 375-381, 2011 | 145 | 2011 |
Polyphosphate nanoparticles on the platelet surface trigger contact system activation JJF Verhoef, AD Barendrecht, KF Nickel, K Dijkxhoorn, E Kenne, ... Blood, The Journal of the American Society of Hematology 129 (12), 1707-1717, 2017 | 143 | 2017 |
Immune responses against domain I of β2‐glycoprotein I are driven by conformational changes B de Laat, M van Berkel, RT Urbanus, B Siregar, P de Groot, M Gebbink, ... Arthritis & Rheumatism 63 (12), 3960-8, 2011 | 117 | 2011 |
SERPINs—from trap to treatment W Sanrattana, C Maas, S De Maat Frontiers in medicine 6, 25, 2019 | 109 | 2019 |
Bradykinin: inflammatory product of the coagulation system Z Hofman, S de Maat, CE Hack, C Maas Clinical reviews in allergy & immunology 51, 152-161, 2016 | 107 | 2016 |
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells E Steller, D Raats, J Koster, B Rutten, K Govaert, B Emmink, N Snoeren, ... | 103 | 2013 |
Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy C Tersteeg, S de Maat, SF De Meyer, MWJ Smeets, AD Barendrecht, ... Circulation 129 (12), 1320-1331, 2014 | 91 | 2014 |
Hereditary angioedema: the plasma contact system out of control S De Maat, ZLM Hofman, C Maas Journal of Thrombosis and Haemostasis 16 (9), 1674-1685, 2018 | 83 | 2018 |
New insights into the role of erythrocytes in thrombus formation VX Du, D Huskens, C Maas, R Al Dieri, PG de Groot, B de Laat Seminars in thrombosis and hemostasis 40 (01), 072-080, 2014 | 82 | 2014 |
Factor XII: form determines function S De Maat, C Maas Journal of Thrombosis and Haemostasis 14 (8), 1498-1506, 2016 | 78 | 2016 |
Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation H Englert, C Rangaswamy, C Deppermann, JP Sperhake, C Krisp, ... EBioMedicine 67, 2021 | 75 | 2021 |